Literature DB >> 26290111

Clinical Risk Factors for the Development of Psoriatic Arthritis Among Patients with Psoriasis: A Review of Available Evidence.

Alexis Ogdie1, J M Gelfand.   

Abstract

Psoriatic arthritis (PsA), a chronic inflammatory arthritis, affects about 10% of patients with psoriasis with higher prevalence seen in patients with more extensive skin disease. Early identification of PsA may result in improved outcomes. While it remains unclear which patients with psoriasis will develop PsA, several studies have identified potential risk factors for PsA among patients with psoriasis. This review examines the basic epidemiologic principles of identifying risk factors and reviews the evidence to date about risk factors for PsA among patients with psoriasis.

Entities:  

Mesh:

Year:  2015        PMID: 26290111      PMCID: PMC5278907          DOI: 10.1007/s11926-015-0540-1

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  40 in total

1.  Obesity in early adulthood as a risk factor for psoriatic arthritis.

Authors:  Razieh Soltani-Arabshahi; Bob Wong; Bing-Jian Feng; David E Goldgar; Kristina Callis Duffin; Gerald G Krueger
Journal:  Arch Dermatol       Date:  2010-07

Review 2.  Spondyloarthritis and the microbiome: new insights from an ancient hypothesis.

Authors:  Julia Manasson; Jose U Scher
Journal:  Curr Rheumatol Rep       Date:  2015-02       Impact factor: 4.592

3.  Association between environmental factors and onset of psoriatic arthritis in patients with psoriasis.

Authors:  Lihi Eder; Tamryn Law; Vinod Chandran; Sutha Shanmugarajah; Hua Shen; Cheryl F Rosen; Richard J Cook; Dafna D Gladman
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-08       Impact factor: 4.794

Review 4.  Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies.

Authors:  D Sugiyama; K Nishimura; K Tamaki; G Tsuji; T Nakazawa; A Morinobu; S Kumagai
Journal:  Ann Rheum Dis       Date:  2010-01       Impact factor: 19.103

Review 5.  Pathogenesis of psoriatic arthritis.

Authors:  Allen P Anandarajah; Christopher T Ritchlin
Journal:  Curr Opin Rheumatol       Date:  2004-07       Impact factor: 5.006

6.  Obesity and the risk of psoriatic arthritis: a population-based study.

Authors:  Thorvardur Jon Love; Yanyan Zhu; Yuqing Zhang; Lindsay Wall-Burns; Alexis Ogdie; Joel M Gelfand; Hyon K Choi
Journal:  Ann Rheum Dis       Date:  2012-05-14       Impact factor: 19.103

7.  Psoriatic arthritis and onycholysis -- results from the cross-sectional Reykjavik psoriatic arthritis study.

Authors:  Thorvardur Jon Love; Johann Eli Gudjonsson; Helgi Valdimarsson; Bjorn Gudbjornsson
Journal:  J Rheumatol       Date:  2012-05-15       Impact factor: 4.666

8.  Personal history of gallstones and risk of incident psoriasis and psoriatic arthritis in U.S. women.

Authors:  L X Tong; S Wu; T Li; A A Qureshi; E L Giovannucci; E Cho
Journal:  Br J Dermatol       Date:  2015-02-15       Impact factor: 9.302

9.  Use of aspirin, non-steroidal anti-inflammatory drugs, and acetaminophen (paracetamol), and risk of psoriasis and psoriatic arthritis: a cohort study.

Authors:  Shaowei Wu; Jiali Han; Abrar A Qureshi
Journal:  Acta Derm Venereol       Date:  2015-02       Impact factor: 4.437

10.  The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004.

Authors:  Shanu Kohli Kurd; Joel M Gelfand
Journal:  J Am Acad Dermatol       Date:  2008-11-20       Impact factor: 11.527

View more
  21 in total

1.  The preclinical phase of PsA: a challenge for the epidemiologist.

Authors:  Alexis Ogdie
Journal:  Ann Rheum Dis       Date:  2017-03-08       Impact factor: 19.103

Review 2.  Strategies to Improve Outcomes in Psoriatic Arthritis.

Authors:  Christopher Ritchlin; Jose U Scher
Journal:  Curr Rheumatol Rep       Date:  2019-12-07       Impact factor: 4.592

3.  Direct healthcare costs and comorbidity burden among patients with psoriatic arthritis in the USA.

Authors:  Joseph F Merola; Vivian Herrera; Jacqueline B Palmer
Journal:  Clin Rheumatol       Date:  2018-07-26       Impact factor: 2.980

4.  Patient characteristics and minimal disease activity in psoriatic arthritis: a transcontinental comparison.

Authors:  Sibel Bakirci; Gizem Ayan; Ummugulsum Gazel; Ilaria Tinazzi; Dilek Solmaz; Esen Kasapoglu; Umut Kalyoncu; Sibel Zehra Aydin
Journal:  Clin Rheumatol       Date:  2021-02-17       Impact factor: 2.980

5.  Pediatric psoriatic arthritis: a population-based cohort study of risk factors for onset and subsequent risk of inflammatory comorbidities.

Authors:  Timothy G Brandon; Cynthia K Manos; Rui Xiao; Alexis Ogdie; Pamela F Weiss
Journal:  J Psoriasis Psoriatic Arthritis       Date:  2018-09-18

6.  Usefulness of the Psoriatic Arthritis Screening and Evaluation Questionnaire to Monitor Disease Activity in Management of Patients with Psoriasis: Findings from the EPI-PSODE Study.

Authors:  Yong Beom Choe; Chul Jong Park; Dae Young Yu; Youngdoe Kim; Hyun Jeong Ju; Sang Woong Youn; Joo-Heung Lee; Byung Soo Kim; Seong Jun Seo; Seok-Kweon Yun; Joonsoo Park; Nack In Kim; Jai Il Youn; Seok-Jong Lee; Min-Geol Lee; Kwang Joong Kim; Young Suck Ro; Hae Jun Song; Bong Seok Shin; Sung Ku Ahn; Ji Yeoun Lee; Young Ho Won; Min Soo Jang; Ki Ho Kim; Myung Hwa Kim; Tae Yoon Kim; Jee-Ho Choi
Journal:  Ann Dermatol       Date:  2019-01-02       Impact factor: 1.444

7.  Psoriasis Characteristics for the Early Detection of Psoriatic Arthritis.

Authors:  Sophie Belman; Jessica A Walsh; Courtney Carroll; Michael Milliken; Benjamin Haaland; Kristina Callis Duffin; Gerald G Krueger; Bing-Jian Feng
Journal:  J Rheumatol       Date:  2021-04-15       Impact factor: 5.346

Review 8.  Apremilast in the therapy of moderate-to-severe chronic plaque psoriasis.

Authors:  Paolo Gisondi; Giampiero Girolomoni
Journal:  Drug Des Devel Ther       Date:  2016-05-25       Impact factor: 4.162

Review 9.  Relationship between Non-Alcoholic Fatty Liver Disease and Psoriasis: A Novel Hepato-Dermal Axis?

Authors:  Alessandro Mantovani; Paolo Gisondi; Amedeo Lonardo; Giovanni Targher
Journal:  Int J Mol Sci       Date:  2016-02-05       Impact factor: 5.923

10.  Prevalence of psoriatic arthritis and costs generated by treatment of psoriatic arthritis patients in the public health system - the case of Poland.

Authors:  Filip Raciborski; Andrzej Śliwczyński; Anna Kłak; Brygida Kwiatkowska; Melania Brzozowska; Małgorzata Tłustochowicz
Journal:  Reumatologia       Date:  2016-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.